Nodalo, Jade S.

HRN: 19-84-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
CEFUROXIME 1.5GM (VIAL)
07/05/2025
07/12/2025
IV
500mg
Q8hours
Acute Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: